Prestige Consumer Healthcare Inc.
PBH- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001295947
No open-market purchases or sales by Prestige Consumer Healthcare Inc. insiders were filed in the last 90 days; 319 institutions reported holding it in 13F filings for Q2 2026, worth $2.54B in total; Maverick Capital is the only superinvestor holding it.
Q3 2024 vs. Q2 2024
How the institutions holding Prestige Consumer Healthcare Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 305 | 2 | 327 | +24 |
| Shares | 51.0M | 8.28M | 51.1M | +8.30M (+19.4%) |
| Value | $3.51B | $569.8M | $3.68B | +$740.1M (+25.1%) |
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (45)
Institutions that held Prestige Consumer Healthcare Inc. at the end of Q3 2024 but not at the end of Q2 2024.
Sold out (21)
Institutions that held Prestige Consumer Healthcare Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Marshall Wace, LLP | 123,920 | $8.53M |
| Balyasny Asset Management LLC | 100,246 | $6.90M |
| Landscape Capital Management, L.L.C. | 58,075 | $4.00M |
| Algert Global LLC | 14,873 | $1.02M |
| Eisler Capital (US) LLC | 11,836 | $814.9K |
| UniSuper Management Pty Ltd | 11,171 | $769.1K |
| Lombard Odier Asset Management (USA) Corp | 7,994 | $550.4K |
| Foundry Partners, LLC | 6,079 | $418.5K |
| Man Group plc | 4,924 | $339.0K |
| Lido Advisors, LLC | 4,057 | $279.3K |
| Innealta Capital, LLC | 1,731 | $119.2K |
| Gladius Capital Management LP | 513 | $35.3K |
| Opal Wealth Advisors, LLC | 377 | $26.0K |
| Headlands Technologies LLC | 342 | $23.5K |
| Crewe Advisors LLC | 231 | $15.9K |
| Triad Wealth Partners, LLC | 60 | $4.13K |
| Stephens Consulting, LLC | 56 | $3.86K |
| Cypress Capital, LLC | 35 | $2.41K |
| RFP Financial Group LLC | 20 | $1.38K |
| Lynx Investment Advisory | 19 | $1.31K |
| IFP Advisors, Inc | 11 | $757 |
Not filed for Q3 2024 yet (2)
Institutions that held Prestige Consumer Healthcare Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 8,275,587 | $569.8M |
| Sofos Investments, Inc. | 1 | $69 |